DIN 02331624 — AZARGA 1 %; 0.5 %
AZARGA is a suspension of Brinzolamide / Timolol marketed by NOVARTIS PHARMACEUTICALS CANADA INC. The full Brinzolamide / Timolol monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02331624
- Brand name
- AZARGA
- Active ingredient
- Brinzolamide / Timolol
- Strength
- 1 %; 0.5 %
- Dosage form
- SUSPENSION
- Route
- OPHTHALMIC
- Manufacturer
- NOVARTIS PHARMACEUTICALS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Topical carbonic anhydrase inhibitor / topical beta-adrenergic blocking agent combination
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.